SA’s medicines regulator has approved a vaginal ring that slowly releases the drug dapirivine, offering women protection from HIV for up to a month at a time.

The development has been hailed by HIV advocates as a milestone in the quest to provide women with more options for reducing their risk of contracting the virus, but it is not clear when it will be available in SA...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.